Age: 93.0
Sex: F
Vaccine: FLUX
Symptoms: Anaemia, Cardiac failure congestive, Death, Myocardial infarction
Clinical narrative: MI; CHF; Anemia; This spontaneous case was retrieved on 12-Jan-2024 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2726726-1) reported by other healthcare professional and concerned a 93-year-old, female patient.  The patient's medical history was not reported. The patient's concomitant medications included acetaminophen, Albuterol sulfate hfa (salbutamol sulfate), amlodipine besylate and Aspirin EC (acetylsalicylic acid). The patient had no known drug allergies.   On 04-Oct-2023, the patient was vaccinated with influenza vaccine (brand not specified; route of administration: injection (reported as 'SYR'); dose, anatomical location, and indication: not reported). The batch number was not reported.  On 11-Oct-2023, seven days after receiving influenza vaccine, the patient had a myocardial infarction (MI), anemia and congestive heart failure (CHF). The patient was admitted to hospice.  On 12-Oct-2023 (discrepantly reported as after two days), the patient was discharged from the hospital. Discharge (DC) summary was not provided.  On 04-Dec-2023, the patient had history and physical examination (H&P). However, the data was not provided.  On an unspecified date in 2023, the patient died. The cause of death was not reported. It was unknown if an autopsy was performed.   The reporter did not provide a causality assessment.  The events of myocardial infarction, anemia and congestive heart failure were assessed as serious due to seriousness criteria of fatal outcome, hospitalization and life-threatening. Additionally, the events of myocardial infarction and congestive heart failure were considered to be medically significant by Physician within Seqirus' Administrative Department.  Company comment: A 93-year-old patient experienced myocardial infarction, anemia, and congestive heart failure seven days after receiving the suspect product influenza vaccine. The patient died from unknown reason, an unspecified amount of time after vaccination. It was unknown if an autopsy was performed. The patient's medical history and diagnostic findings were not provided. The patient's advanced age and the therapy involving Amlodipine besylate and Aspirin EC (acetylsalicylic acid), which indicates underlying cardiovascular conditions, as well as considering biological implausibility, suggest that the causal role of the suspect vaccine is assessed as not related.; Sender's Comments: A 93-year-old patient experienced myocardial infarction, anemia, and congestive heart failure seven days after receiving the suspect product influenza vaccine. The patient died from unknown reason, an unspecified amount of time after vaccination. It was unknown if an autopsy was performed. The patient's medical history and diagnostic findings were not provided. The patient's advanced age and the therapy involving Amlodipine besylate and Aspirin EC (acetylsalicylic acid), which indicates underlying cardiovascular conditions, as well as considering biological implausibility, suggest that the causal role of the suspect vaccine is assessed as not related.; Reported Cause(s) of Death: MI; Anemia; CHF